Pneumocystosis: A network survey in the Paris area 2003-2008

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 5, 2011, Pages 673-675

  Magne, D ^a,l   Angoulvant, A ^a   Botterel, F ^b   Bouges Michel, C ^c   Bougnoux, M E ^d   Bouree, P ^e   Chochillon, C ^f   Cornet, M ^g   Dannaoui, E ^h   Fekkar, A ^a   Galeazzi, G ⁱ   Yera, H ^j   Sarfati, C ^k   Roux, P ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c AVICENNE HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e BICÊTRE HOSPITAL   (France)

^f BICHAT HOSPITAL   (France)

^g HÔTEL DIEU   (France)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁱ HÔPITAL LOUIS MOURIER   (France)

^j NONE   (France)

^k SAINT LOUIS HOSPITAL   (France)

^l HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; CYTOTOXIC AGENT; DIHYDROPTEROATE SYNTHASE; SULFANILAMIDE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DHPS GENE; FEMALE; FRANCE; FUNGAL STRAIN; GENE; GENE MUTATION; GENETIC MARKER; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NONHUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PNEUMOCYSTOSIS; PRESCRIPTION; PRIORITY JOURNAL; TRANSPLANTATION;

ADRENAL CORTEX HORMONES; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE, FUNGAL; FEMALE; GENOTYPE; HIV INFECTIONS; HOSPITALS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; NEOPLASMS; PARIS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; SULFANILAMIDES; TRANSPLANTATION;

EID: 79956100994     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-010-1139-0     Document Type: Article

References (7)

1. Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala F, Dary M et al (2002) Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 21:523-531 (Pubitemid 35013591)
2. Magne D, Lacube P, Angoulvant A, Meliani L, Botterel F, Bougnoux ME et al. (2007) Pneumocystosis: survey in 14 hospitals from Assistance publique-Hôpitaux de Paris (AP-HP), France, 2003-2005. Bulletin Epidémiologique Hebdomadaire, InVS (France), BEH 5/6 février 2007.
3. Stringer J, Beard CB, Miller RF, Wakefield AE (2002) A new name (Pneumocystis jirovecii) for Pneumocystis from humans. Emerg Infect Dis 8:891-896 (Pubitemid 35000804)
4. Meneau I, Sanglard D, Bille J, Hauser PM (2004) Pneumocystis jirovecii dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae. Antimicrob Agents Chemother 48:2610-2616 (Pubitemid 38823433)
5. Magne D, Lacube P, Angoulvant A, Meliani L, Botterel F, Bougnoux ME, Chochillon C, Cornet M, Dannaoui E, Datry A, Dunand J, Galeazzi G, Bouges-Michel C, Yera H, Sarfati C, Roux P (2006) Pneumocystosis: survey and DHPS genotype analysis in 14 Parisian hospitals in 2003 and 2004. J Eukaryot Microbiol 53:S106-S107 (Pubitemid 44813347)
6. Friaza V, Montes-Cano MA, Respaldiza N, Morilla R, Calderón EJ, de la Horra C (2009) Prevalence of dihydropteroate synthase mutations in Spanish patients with HIV-associated Pneumocystis pneumonia. Diagn Microbiol Infect Dis 64:104-105
7. Moukhlis R, Boyer J, Lacube P, Bolognini J, Roux P, Hennequin C (2010) Linking Pneumocystis jirovecii sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae. Clin Microbiol Infect 16:501-507